Abstract:Background Increasing research suggests that mitochondrial defect plays a major role in pulmonary hypertension（PH） pathogenesis. Mitochondrial dynamics and quality control have a central role in the maintenance of the cell proliferation and apoptosis balance. However, the molecular mechanism underlying of this balance is still unknown. Methods To clarify the biological effects of hypoxic air exposure and hypoxia-inducible factor-1α（HIF-1α） on pulmonary arterial smooth muscle cell（PASMC） and pulmonary arterial hypertension rats, the cells were cultured in a hypoxic chamber under oxygen concentrations. Cell viability, reactive oxygen species level, cell death, mitochondrial morphology, mitochondrial membrane potential, mitochondrial function and mitochondrial biosynthesis, as well as fission-and fusion-related proteins, were measured under hypoxic conditions. In addition, rats were maintained under hypoxic conditions, and the right ventricular systolic pressure, right ventricular hypertrophy index and right ventricular weight/body weight ratio were examined and recorded. Further, we assessed the role of HIF-1α in the development and progression of PH using HIF-1α gene knockdown using small interfering RNA transfection. Mdivi-1 treatment was performed before hypoxia to inhibit dynamin-related protein 1（Drp1）. Results We found that HIF-1α expression was increased during hypoxia, which was crucial for hypoxia-induced mitochondrial dysfunction and hypoxia-stimulated PASMCs proliferation and apoptosis. We also found that targeting mitochondrial fission Drp1 by mitochondrial division inhibitor Mdivi-1 was effective in PH model rats. The results showed that mitochondrial dynamics were involved in the pulmonary vascular remodeling under hypoxia in vivo and in vitro. Furthermore, HIF-1α also modulated mitochondrial dynamics in pulmonary vascular remodeling under hypoxia through directly regulating the expression of Drp1. Conclusions In conclusion, our data suggests that abnormal mitochondrial dynamics could be a marker for the early diagnosis of PH and monitoring disease progression. Further research is needed to study the signaling pathways that govern mitochondrial fission/fusion in PH.

HIF-1 signaling: an emerging mechanism for mitochondrial dynamics

The role of mitochondrial dynamics in disease

The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.

Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets

HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

Interplay between Hypoxia Inducible Factor-1 and mitochondria in cardiac diseases

The Crosstalk Between HIFs and Mitochondrial Dysfunctions in Cancer Development.

Molecular regulation of mitochondrial dynamics in cardiac disease

HIF-1: structure, biology and natural modulators

Mitochondrial Dynamics, Mitophagy, and Mitochondria–Endoplasmic Reticulum Contact Sites Crosstalk Under Hypoxia

Mitochondrial dynamics in health and disease: mechanisms and potential targets

Hypoxia-induced NAD+ Interventions Promote Tumor Survival and Metastasis by Regulating Mitochondrial Dynamics.

Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics

Hypoxia Promotes Pulmonary Vascular Remodeling Via HIF-1α to Regulate Mitochondrial Dynamics

HIF‐1α: Its notable role in the maintenance of oxygen, bone and iron homeostasis (Review)

HIF-1α Protects Against Oxidative Stress by Directly Targeting Mitochondria

Hypoxia-induced Mitochondrial Fission Regulates the Fate of Bone Marrow Mesenchymal Stem Cells by Maintaining HIF1α Stabilization

Potential biomarkers and targets of mitochondrial dynamics

The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance

Oxygen homeostasis and cardiovascular disease: A role for HIF?

Research Progress on the Role of Transcription Factor HIF-1α and Its Signal Pathway in the Pathogenesis